A brand new ‘gamechanging’ drug is set to make waves in the medical world as thousands of people with obesity in England will be able to access Wegovy, Semaglutide, on the NHS. Dr Iqbal Malik, Consultant Cardiologist at OneWelbeck Heart Health, takes a closer look at the drug and its impact. Please note that this drug is not available to patients at OneWelbeck Heart Health.

Dr Wedad Abdelrahman is a fully qualified UK-trained consultant dermatologist, registered with the General Medical Council with a special interest in paediatric and medical dermatology.

Dr. Webster is a consultant gastroenterologist here at OneWelbeck. He is also the clinical lead for hepatopancreaticobiliary (HPB) medicine at University College London Hospital. He is Vice President of Endoscopy at the British Society of Gastroenterology, on the Council of the European Society of Gastrointestinal Endoscopy.

Miss Lisa Webber specialises in disorders of ovarian follicle development, and all aspects of polycystic ovary syndrome, including the fertility and non-reproductive effects.

Mr Mark Webb is a Consultant Orthopaedic Surgeon at OneWelbeck. His practice is focused on keeping people active. Mr Webb believes in offering a range of treatment options that are tailored to the individual's needs.

Weakness is the feeling of body fatigue or tiredness

Written By Dr Iqbal Malik, Consultant Cardiologist

Mr Wayne Ellis is a Clinical Scientist in Audiology at OneWelbeck ENT.

Dr Waung focuses primarily on bone health but also all endocrine problems including sex hormone deficiency fertility, diabetes, thyroid problems and hypoparathyroidism.